Telephone
61.3.9538.3333
Address
16 Miles Street Mulgrave, Victoria (VIC) 3170
Description
Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. It has developed and patented miniaturised confocal microscopes. Its products include FIVE2 and Customisation options. The company was founded by Martin Harris and Peter Maxwell Delaney in 1994 and is headquartered in Mulgrave, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.07 - 0.14
Trade Value (12mth)
AU$3,092.00
1 week
3.26%
1 month
18.75%
YTD
-3.05%
1 year
-3.05%
All time high
0.646724
EPS 3 yr Growth
89.200%
EBITDA Margin
-292.20%
Operating Cashflow
-$3m
Free Cash Flow Return
-61.90%
ROIC
-85.40%
Interest Coverage
-152.00
Quick Ratio
1.60
Shares on Issue (Fully Dilluted)
626m
HALO Sector
Healthcare
Next Company Report Date
30-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
OIL September 2023 Quarterly Report and Appendix 4C
×
OIL September 2023 Quarterly Report and Appendix 4C |
31 October 22 |
OIL September 2022 Quarterly Report and Appendix 4C
×
OIL September 2022 Quarterly Report and Appendix 4C |
31 October 19 |
Optiscan Presentation at AusBiotech Conference
×
Optiscan Presentation at AusBiotech Conference |
31 March 23 |
Change of Director's Interest Notice - K Borg
×
Change of Director's Interest Notice - K Borg |
31 July 23 |
Application for quotation of securities - OIL
×
Application for quotation of securities - OIL |
31 January 22 |
OIL December 2021 Quarterly Report and Appendix 4C
×
OIL December 2021 Quarterly Report and Appendix 4C |
31 August 23 |
OIL Appendix 4E and June 2023 Annual Report
×
OIL Appendix 4E and June 2023 Annual Report |
31 August 23 |
Appendix 4G & Corporate Governance Statement
×
Appendix 4G & Corporate Governance Statement |
31 August 22 |
Appendix 4E and 2022 Annual Report
×
Appendix 4E and 2022 Annual Report |
31 August 22 |
Appendix 4G & Corporate Governance Statement
×
Appendix 4G & Corporate Governance Statement |
31 August 20 |
Appendix 4E and 2020 Annual Report
×
Appendix 4E and 2020 Annual Report |
31 August 18 |
Appendix 4E and 2018 Annual Report
×
Appendix 4E and 2018 Annual Report |
30 September 13 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 08 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 October 18 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 October 15 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 November 18 |
AGM Presentation
×
AGM Presentation |
30 November 18 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 May 23 |
Optiscan Launches Entitlement Offer to Raise $16.7M
×
Optiscan Launches Entitlement Offer to Raise $16.7M |
30 May 23 |
Optiscan Entitlement Issue Prospectus
×
Optiscan Entitlement Issue Prospectus |
30 May 23 |
Proposed issue of securities - OIL
×
Proposed issue of securities - OIL |
30 May 23 |
Entitlement Offer Timetable Update
×
Entitlement Offer Timetable Update |
30 March 23 |
Change of Director's Interest Notice - R Cooke
×
Change of Director's Interest Notice - R Cooke |
30 January 23 |
Optiscan partners with Prolucid to develop AI Algorithms
×
Optiscan partners with Prolucid to develop AI Algorithms |
30 August 21 |
Appendix 4E and 2021 Annual Report
×
Appendix 4E and 2021 Annual Report |
30 August 21 |
OIL FY21 Annual Results Presentation
×
OIL FY21 Annual Results Presentation |
30 August 19 |
Appendix 4E and 2019 Annual Report
×
Appendix 4E and 2019 Annual Report |
29 September 11 |
Annual Report to shareholders
×
Annual Report to shareholders |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.